Neurotransmitter -Dopaminergic drugs

The dopaminergic drugs acts as neurotransmitters in Parkinson’s disease. In the brain these dopaminergic drugs or actions increase the dopamine-related activity.  Proteins, enzymes that regulate the biosynthesis or metabolism of dopamine and neurons that synthesize dopamine can also be classified as dopaminergic.
  • Selective Serotonin Inverse Agonists (SSIA)
  • Cocaine and amphetamine regulated transcript (CART)
  • Mechanism of impulse transmission
  • Dopaminergic pathways
  • Brain neurotransmitter systems
  • Reuptake inhibitors/transporter blockers
  • Receptor antagonists/receptor blockers

Are you interested in

Mail us at

Drop us a mail for program enquiry
parkinsons@alliedconferences.org
Sponser/Exhibiting/advertising
parkinsonsdisease@alliedmeetings.com
General queries
parkinsons@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2018-2019 Allied Academies, All Rights Reserved.